Cargando…
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice: Ischemia and Reparixin
OBJECTIVE: Ischemic stroke may result from transient or permanent reductions of regional cerebral blood flow. Polymorphonuclear neutrophils have been described as the earliest inflammatory cells to arrive in ischemic tissue. CXCR1/2 receptors are involved in the recruitment of these cells. However,...
Autores principales: | da Cunha Sousa, Larissa Fonseca, Coelho, Fernanda Matos, Rodrigues, David Henrique, Campos, Alline Cristina, da Silva Barcelos, Lucíola, Teixeira, Mauro Martins, Alvarenga Rachid, Milene, Teixeira, Antonio Lúcio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611745/ https://www.ncbi.nlm.nih.gov/pubmed/23644861 http://dx.doi.org/10.6061/clinics/2013(03)OA17 |
Ejemplares similares
-
The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1
(low) Mice
por: Verachi, Paola, et al.
Publicado: (2022) -
The protective effects of reparixin against endothelial ischemia-reperfusion injury
por: Thitiwuthikiat, Piyanuch, et al.
Publicado: (2022) -
A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
por: Goldstein, Lori J., et al.
Publicado: (2020) -
Multiple anti-tumor effects of Reparixin on thyroid cancer
por: Liotti, Federica, et al.
Publicado: (2017) -
Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
por: Goldstein, Lori J., et al.
Publicado: (2020)